CONTINUE TO SITE >
OR WAIT 15 SECS
Search
Spotlight
Contact Lens Update
Diabetic Eye Disease
Branded vs Generics
Glaucoma Management
Vision Innovation
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoint
Myopia Management
Clinical
Allergy
Cataract
Contact Lenses
COVID-19
Dry Eye
Glaucoma
LASIK
OCT
Refractive Surgery
Retina
News
All News
Practice Management
Media
Expert Interviews
MJH Broadcast Channel
Podcasts
Viewpoints
Conferences
Conference Coverage
Conference Listing
Blog
Publications
Digital Edition
iTech
Resources
Job Board
Sponsored Resources
Subscribe
eNewsletter
Print Subscription
Search
Spotlight
Contact Lens Update
Diabetic Eye Disease
Branded vs Generics
Glaucoma Management
Vision Innovation
Dry Eye Viewpoint
Diabetic Eye Disease Viewpoint
Myopia Management
Clinical
See All >
Allergy
Cataract
Contact Lenses
COVID-19
Dry Eye
Glaucoma
LASIK
OCT
Refractive Surgery
Retina
Advancements in dry eye managment
Introduction and overview
Consequences and epidemiology of untreated dry eye
Diagnosis and overlooking asymptomatic patients with DED
Standard testing and assessment for DED
General Principles of Treatment of DED
OD and MD communication for optimal care
Review of artificial tears for DED
Corticosteroids and Immunomodulators for the treatment of dry eye
The role of nutritional supplements and antibiotics in DED
How to treat meibomian gland dysfunction
In-office procedures and patient resistance for DED treatments
Treatments for aqueous dry eye
Challenges in the management of DED
Counseling and formulary concerns for DED therapies
Overlapping diseases and COVID-19's impact
Agents in the pipeline for DED
Novel agents in the pipeline for DED
Next >>